Kamada Ltd
KMDA7.070USD
-0.020-0.28%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
407.81MMarket Cap
20.11P/E TTM
More Details of Kamada Ltd Company
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Kamada Ltd Info
Ticker SymbolKMDA
Company nameKamada Ltd
IPO dateAug 01, 2005
CEOLondon (Amir)
Number of employees374
Security typeOrdinary Share
Fiscal year-endAug 01
Address2 Holtzman St., Science Park
CityREHOVOT
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryIsrael
Postal code7670402
Phone97289406472
Websitehttps://www.kamada.com/
Ticker SymbolKMDA
IPO dateAug 01, 2005
CEOLondon (Amir)
Company Executives of Kamada Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Director
Director
631.14K
--
Mr. David Tsur
Mr. David Tsur
Deputy Chairman of the Board
Deputy Chairman of the Board
607.93K
--
Mr. Amir London
Mr. Amir London
Chief Executive Officer
Chief Executive Officer
61.88K
+3.12%
Ms. Orit Pinchuk
Ms. Orit Pinchuk
Vice President - Regulatory Affairs and Quality R&D
Vice President - Regulatory Affairs and Quality R&D
12.13K
--
Ms. Yael Brenner
Ms. Yael Brenner
Vice President - Quality
Vice President - Quality
6.27K
--
Mr. Barak Bashari
Mr. Barak Bashari
Vice President - Operations
Vice President - Operations
--
--
Dr. Michal Stein
Dr. Michal Stein
Vice President and Medical Director for Immunology
Vice President and Medical Director for Immunology
--
--
DR. Michal Ayalon
DR. Michal Ayalon
Vice President - Research & Development
Vice President - Research & Development
--
--
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
--
--
Dr. Estery Giloz-Ran
Dr. Estery Giloz-Ran
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Director
Director
631.14K
--
Mr. David Tsur
Mr. David Tsur
Deputy Chairman of the Board
Deputy Chairman of the Board
607.93K
--
Mr. Amir London
Mr. Amir London
Chief Executive Officer
Chief Executive Officer
61.88K
+3.12%
Ms. Orit Pinchuk
Ms. Orit Pinchuk
Vice President - Regulatory Affairs and Quality R&D
Vice President - Regulatory Affairs and Quality R&D
12.13K
--
Ms. Yael Brenner
Ms. Yael Brenner
Vice President - Quality
Vice President - Quality
6.27K
--
Mr. Barak Bashari
Mr. Barak Bashari
Vice President - Operations
Vice President - Operations
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
U.S.A
25.34M
56.61%
Israel
8.00M
17.88%
Latin America
5.27M
11.77%
Canada
2.56M
5.72%
Europe
2.38M
5.33%
Other
1.21M
2.69%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Fri, Nov 21
Updated: Fri, Nov 21
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
First Israel Mezzanine Investors Ltd.
38.29%
Gov Financial Holdings, Ltd.
4.86%
Phoenix Investment and Finances Ltd
2.87%
Renaissance Technologies LLC
1.51%
Recanati (Leon Yehuda)
1.09%
Other
51.38%
Shareholders
Shareholders
Proportion
First Israel Mezzanine Investors Ltd.
38.29%
Gov Financial Holdings, Ltd.
4.86%
Phoenix Investment and Finances Ltd
2.87%
Renaissance Technologies LLC
1.51%
Recanati (Leon Yehuda)
1.09%
Other
51.38%
Shareholder Types
Shareholders
Proportion
Private Equity
38.29%
Corporation
4.86%
Investment Advisor
4.33%
Investment Advisor/Hedge Fund
2.86%
Hedge Fund
2.45%
Individual Investor
2.34%
Research Firm
1.61%
Pension Fund
0.14%
Bank and Trust
0.02%
Other
43.10%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
77
26.81M
46.48%
-3.11M
2025Q2
80
32.16M
55.76%
-1.16M
2025Q1
80
31.87M
55.42%
-1.29M
2024Q4
72
32.96M
57.32%
-768.38K
2024Q3
87
33.30M
57.92%
-790.28K
2024Q2
91
33.17M
57.70%
-784.97K
2024Q1
93
32.46M
56.47%
-1.61M
2023Q4
102
32.56M
56.63%
-1.63M
2023Q3
106
34.53M
63.12%
+10.56M
2023Q2
108
21.99M
49.05%
-2.19M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
First Israel Mezzanine Investors Ltd.
22.08M
38.29%
--
--
Dec 31, 2024
Gov Financial Holdings, Ltd.
2.80M
4.86%
-55.95K
-1.96%
Dec 31, 2024
Phoenix Investment and Finances Ltd
1.65M
2.87%
--
--
Jun 30, 2025
Renaissance Technologies LLC
832.00K
1.44%
+23.70K
+2.93%
Jun 30, 2025
Recanati (Leon Yehuda)
631.14K
1.09%
--
--
Dec 31, 2024
Tsur (David)
607.93K
1.05%
--
--
Dec 31, 2024
Wells Fargo Advisors
610.47K
1.06%
+1.88K
+0.31%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
411.59K
0.71%
+3.27K
+0.80%
Aug 31, 2025
Essex Investment Management Company, LLC
323.83K
0.56%
+323.83K
--
Jun 30, 2025
Acadian Asset Management LLC
263.56K
0.46%
+7.92K
+3.10%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Avantis International Small Cap Equity ETF
0.01%
DFA Dimensional International Small Cap ETF
0.01%
Dimensional International Core Equity Market ETF
0%
ARK Israel Innovative Technology ETF
0%
Avantis International Equity ETF
0%
Vanguard Total World Stock Index Fund
0%
Vanguard ESG International Stock ETF
0%
Schwab International Small-Cap Equity ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
DFA Dimensional International Small Cap Value ETF
0%
Avantis International Small Cap Equity ETF
Proportion0.01%
DFA Dimensional International Small Cap ETF
Proportion0.01%
Dimensional International Core Equity Market ETF
Proportion0%
ARK Israel Innovative Technology ETF
Proportion0%
Avantis International Equity ETF
Proportion0%
Vanguard Total World Stock Index Fund
Proportion0%
Vanguard ESG International Stock ETF
Proportion0%
Schwab International Small-Cap Equity ETF
Proportion0%
DFA Dimensional International Core Equity 2 ETF
Proportion0%
DFA Dimensional International Small Cap Value ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Kamada Ltd?
The top five shareholders of Kamada Ltd are:
First Israel Mezzanine Investors Ltd. holds 22.08M shares, accounting for 38.29% of the total shares.
Gov Financial Holdings, Ltd. holds 2.80M shares, accounting for 4.86% of the total shares.
Phoenix Investment and Finances Ltd holds 1.65M shares, accounting for 2.87% of the total shares.
Renaissance Technologies LLC holds 832.00K shares, accounting for 1.44% of the total shares.
Recanati (Leon Yehuda) holds 631.14K shares, accounting for 1.09% of the total shares.
First Israel Mezzanine Investors Ltd. holds 22.08M shares, accounting for 38.29% of the total shares.
Gov Financial Holdings, Ltd. holds 2.80M shares, accounting for 4.86% of the total shares.
Phoenix Investment and Finances Ltd holds 1.65M shares, accounting for 2.87% of the total shares.
Renaissance Technologies LLC holds 832.00K shares, accounting for 1.44% of the total shares.
Recanati (Leon Yehuda) holds 631.14K shares, accounting for 1.09% of the total shares.
What are the top three shareholder types of Kamada Ltd?
The top three shareholder types of Kamada Ltd are:
First Israel Mezzanine Investors Ltd.
Gov Financial Holdings, Ltd.
Phoenix Investment and Finances Ltd
First Israel Mezzanine Investors Ltd.
Gov Financial Holdings, Ltd.
Phoenix Investment and Finances Ltd
How many institutions hold shares of Kamada Ltd (KMDA)?
As of 2025Q3, 77 institutions hold shares of Kamada Ltd, with a combined market value of approximately 26.81M, accounting for 46.48% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -9.28%.
What is the biggest source of revenue for Kamada Ltd?
In FY2025Q2, the -- business generated the highest revenue for Kamada Ltd, amounting to -- and accounting for --% of total revenue.
